| Product Code: ETC9407880 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market - Industry Life Cycle |
3.4 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market - Porter's Five Forces |
3.5 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of metastatic castrate-resistant prostate cancer in South Korea |
4.2.2 Growing awareness and early diagnosis of the disease |
4.2.3 Technological advancements in prostate cancer treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with advanced prostate cancer treatments |
4.3.2 Limited access to specialized healthcare facilities in certain regions of South Korea |
4.3.3 Stringent regulatory requirements for approval of new treatment options |
5 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Trends |
6 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market, By Types |
6.1 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Hormone Therapies, 2021- 2031F |
6.1.4 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Enzalutamide, 2021- 2031F |
6.1.5 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Abiraterone, 2021- 2031F |
6.1.6 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.5 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Import-Export Trade Statistics |
7.1 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Export to Major Countries |
7.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Imports from Major Countries |
8 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Key Performance Indicators |
8.1 Average survival rate of patients with metastatic castrate-resistant prostate cancer |
8.2 Adoption rate of innovative treatment modalities |
8.3 Number of clinical trials conducted for developing new prostate cancer treatments |
9 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market - Opportunity Assessment |
9.1 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market - Competitive Landscape |
10.1 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 South Korea Metastatic Castrate Resistant Prostate Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here